This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Connective tissue disorders

Combining symptoms, signs and laboratory tests best for diagnosing giant cell arteritis
Reducing corticosteroid use in rheumatoid arthritis
Minor differences in efficacy between biologics for rheumatoid arthritis
Still no effective treatment for patients with CLE
Hydroxychloroquine not protective in those with SLE
Worsening of disease in those with spondyloarthritis during the COVID-19 lockdown
Expert view: 2019 update of EULAR recommendations for the management of SLE
Study finds molecule in lymphatic system implicated in autoimmune diseases
Expert view: EULAR recommendations for management of APS
Half of lupus rashes harbour high levels of bacteria responsible for infections
Research offers new hope for the treatment of lupus
Novel cancer therapy leads to insights into lupus
New classification criteria for IgG4-related disease released
Atmospheric and environmental changes impact lupus flares


Popular articles

Aspirin use associated with improved survival but only for bladder and breast cancer
Metformin use in diabetes protective against COVID-19-related mortality
Low levels of alcohol intake linked to greater risk of atrial fibrillation
Bimagrumab leads to significant fat loss in obese, type 2 diabetic patients
Higher convalescent plasma antibody titre levels associated with lower risk of death in COVID-19




 
Hospital Healthcare Europe
 
LinkedIn Logo Footer  Twitter Logo Footer

Ⓒ Cogora 2021
Cogora Limited, 140 London Wall, London EC2Y 5DN, Registered in the United Kingdom. Reg. No. 2147432

Hospital Healthcare Europe
HOPE Logo Footer